![Pascal Krotee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pascal Krotee
Investitore di Private Equity presso
RiverVest Venture Management LLC
Profilo
Pascal Krotee currently works at RiverVest Venture Management LLC, as Principal from 2023.
Dr. Krotee also formerly worked at Holoclara, Inc., as Board of Directors from 2019 to 2021, Kairos Venture Investments LLC, as Investment Associate from 2017 to 2021, and Linnaeus Therapeutics, Inc., as Linnaeus Therapeutics from 2019 to 2021.
Dr. Krotee received her doctorate degree from the University of California, Los Angeles and undergraduate degree from the University of California, Irvine.
Posizioni attive di Pascal Krotee
| Società | Posizione | Inizio |
|---|---|---|
RiverVest Venture Management LLC
 RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Partners invests in companies located in the United States. The firm focuses on life sciences, primarily on medical devices and biopharma sectors. It provides financing for early-stage capital requirements. It act as a lead investor. | Investitore di Private Equity | 01/12/2023 |
Precedenti posizioni note di Pascal Krotee
| Società | Posizione | Fine |
|---|---|---|
Kairos Venture Investments LLC
 Kairos Venture Investments LLC Investment ManagersFinance Kairos Ventures invests in companies located in the United States. The firm focuses on life sciences, physical sciences, and technology sector. It provides financing for early-stage capital requirements with an investment size of USD 0.15 - USD 20 million. | Investitore di Private Equity | 28/02/2021 |
Holoclara, Inc.
 Holoclara, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy drugs to autoimmune disorders | Direttore/Membro del Consiglio | 28/02/2021 |
Linnaeus Therapeutics, Inc.
 Linnaeus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Direttore/Membro del Consiglio | 28/02/2021 |
Formazione di Pascal Krotee
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
7
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Partners invests in companies located in the United States. The firm focuses on life sciences, primarily on medical devices and biopharma sectors. It provides financing for early-stage capital requirements. It act as a lead investor. | Finance |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Ventures invests in companies located in the United States. The firm focuses on life sciences, physical sciences, and technology sector. It provides financing for early-stage capital requirements with an investment size of USD 0.15 - USD 20 million. | Finance |
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer | Health Technology |
Holoclara, Inc.
Holoclara, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy drugs to autoimmune disorders | Health Technology |
